GlassScriptPhysician profile
Daniel Torino
NPI 1780079111
$9,357.28
in general payments reported to CMS, 2019-2025
8 companies · $1,577 in 2025
The $1,577 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,417 · 2022: $3,457 · 2023: $1,970 · 2024: $936 · 2025: $1,577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,271 · Food and Beverage: $2,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,271.42 |
| Food and Beverage | $2,211.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,372.01 | 2022-2025 | Mako, Triathlon, Tritanium |
| Novus Surgical Solutions LLC | $1,269.80 | 2021 | |
| Dilon Technologies, INC. | $178.45 | 2025 | Hemoblast Bellows |
| Depuy Synthes Sales INC. | $161.84 | 2023-2025 | Attune, Velys, Emphasys |
| Acumed LLC | $147.19 | 2021 | |
| Medical Device Business Services, INC. | $123.67 | 2024 | Attune |
| Zimmer Biomet Holdings, INC. | $89.39 | 2022 | |
| Zimvie INC. | $14.93 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Torino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.